{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:54:19Z","timestamp":1757778859718},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jss.2015.03.048","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T13:53:22Z","timestamp":1428760402000},"page":"85-90","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of peritoneal carcinomatosis with intraperitoneal administration of Ad-hARF"],"prefix":"10.1016","volume":"197","author":[{"given":"Barur R.","family":"Rajeshkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giles F.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2015.03.048_bib1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2015.03.048_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2015.03.048_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2015.03.048_bib4","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2015.03.048_bib5","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2015.03.048_bib6","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2015.03.048_bib7","first-page":"3810","article-title":"Liposome-mediated in\u00a0vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity","volume":"55","author":"Aoki","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2015.03.048_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1101\/sqb.2005.70.004","article-title":"p53-dependent and -independent functions of the Arf tumor suppressor","volume":"70","author":"Sherr","year":"2005","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.jss.2015.03.048_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/labinvest.3780230","article-title":"Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer","volume":"81","author":"Burri","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.jss.2015.03.048_bib10","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/MCB.26.6.2360-2372.2006","article-title":"Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis","volume":"26","author":"Paliwal","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jss.2015.03.048_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/cdd.2009.140","article-title":"An ARF\/CTBP2 complex regulates BH3-only gene expression and p53-independent apoptosis","volume":"17","author":"Kovi","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jss.2015.03.048_bib12","first-page":"1020","article-title":"N, N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells","volume":"39","author":"Dexter","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2015.03.048_bib13","first-page":"1171","article-title":"Human tumor suppressor arf impedes s-phase progression independent of p53","volume":"62","author":"Yarbrough","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2015.03.048_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.mt.6300346","article-title":"Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein","volume":"16","author":"Johansson","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.jss.2015.03.048_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404021","article-title":"Inhibition of human leukemia xenograft in nude mice by adenovirus-mediated tissue inhibitor of metalloproteinase-3","volume":"20","author":"Yu","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jss.2015.03.048_bib16","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3748\/wjg.v13.i13.1938","article-title":"Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model","volume":"13","author":"Jie","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2015.03.048_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/hum.1998.9.5-707","article-title":"Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer","volume":"9","author":"Putzer","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jss.2015.03.048_bib18","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/0008-5472.CAN-06-3399","article-title":"Attenuation of the glucocorticoid response during Ad5il-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors","volume":"67","author":"Raja Gabaglia","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2015.03.048_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.2910630512","article-title":"Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in\u00a0vitro and in\u00a0vivo","volume":"63","author":"Cirielli","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2015.03.048_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00000658-199507000-00013","article-title":"Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene","volume":"222","author":"Smythe","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2015.03.048_bib21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.gt.3300516","article-title":"Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase\/ganciclovir and il-2 treatments","volume":"4","author":"Coll","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.jss.2015.03.048_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2005.05.001","article-title":"Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant","volume":"236","author":"Li","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jss.2015.03.048_bib23","first-page":"235","article-title":"Cancer-specific gene therapy","volume":"54","author":"Lo","year":"2005","journal-title":"Adv Genet"},{"key":"10.1016\/j.jss.2015.03.048_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00535-004-1490-y","article-title":"Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer","volume":"40","author":"Ono","year":"2005","journal-title":"J Gastroenterol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002248041500311X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002248041500311X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T15:51:18Z","timestamp":1537717878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002248041500311X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S002248041500311X"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2015.03.048","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of peritoneal carcinomatosis with intraperitoneal administration of Ad-hARF","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2015.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}